Yakira Capital Management, Inc.
Position in VRXA — Veraxa Biotech AG - Post de-SPAC
CIK 1584639
Westport, CT
Position in VRXA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$0
New position
Shares Held
98,360
first reported quarter
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Yakira Capital Management, Inc. holds $3,480,869 across 8 Biotechnology names. VRXA ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNA |
Atrium Therapeutics, Inc.
|
133,047 | $1,789,482 | |
| 2 | 6,000 | $796,380 | |||
| 3 | LSTA |
Lisata Therapeutics, Inc.
|
138,561 | $471,107 | |
| 4 | TECH |
BIO-TECHNE Corp
|
6,000 | $423,900 | |
| 5 | ESLA |
Estrella Immunopharma, Inc.
|
46,285 | $0 | |
| 6 | 10,311 | $0 | |||
| 7 | TVGN |
Tevogen Inc.
|
65,128 | $0 | |
| 8 | VRXA |
Veraxa Biotech AG - Post de-SPAC
This page
|
98,360 | $0 |
No Holdings History
No holdings records found for this institution in VRXA.